ResMed Inc (RMD) Stock Analysis

ResMed Inc (RMD) is a publicly traded company in the HEALTHCARE sector. It trades at $203.85, carries a market capitalization of $30.24B, a price-to-earnings ratio of 19.83, a dividend yield of 0.01%. This page summarizes the public market data, fundamentals, and frequently asked questions for RMD, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL INSTRUMENTS & SUPPLIES

Exchange: NYSE

Key Metrics

Price: $203.85
Market Cap: $30.24B
P/E Ratio: 19.83
EPS: $10.51
Dividend Yield: 0.01%
52-Week High: $291.57
52-Week Low: $180.27

Market Sentiment

ResMed Inc currently has a Neutral sentiment score of 0.10.

About ResMed Inc

ResMed Inc. is a leading San Diego-based healthcare technology company specializing in cloud-connected devices and software solutions for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory disorders. With a strong focus on enhancing patient outcomes through innovative technology, ResMed leverages its expertise in digital health to offer integrated solutions that drive both clinical and operational efficiencies. The company is well-positioned for ...

GNG Research Analysis

GNG Research scores ResMed Inc (RMD) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for RMD.

Frequently Asked Questions

What is RMD's current dividend yield?

ResMed Inc (RMD) has a current dividend yield of 0.01%.

Does RMD pay dividends?

Yes, ResMed Inc pays dividends with a current yield of 0.01%.

What is RMD's P/E ratio?

ResMed Inc has a price-to-earnings (P/E) ratio of 19.83.

What is RMD's market cap?

ResMed Inc (RMD) has a market capitalization of $30.24B with a current stock price of $203.85.